CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $737,000 | 0.0% | 39,862 | 0.0% | 0.02% | -46.4% |
| Q3 2018 | $737,000 | -19.3% | 39,862 | -0.2% | 0.03% | -24.3% |
| Q2 2018 | $913,000 | -24.5% | 39,924 | -6.1% | 0.04% | -27.5% |
| Q1 2018 | $1,209,000 | +34.5% | 42,502 | -0.2% | 0.05% | +37.8% |
| Q4 2017 | $899,000 | -35.1% | 42,600 | -44.1% | 0.04% | -32.7% |
| Q3 2017 | $1,386,000 | +16.9% | 76,275 | -0.3% | 0.06% | +12.2% |
| Q2 2017 | $1,186,000 | – | 76,498 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |